Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Selincro (nalmefene) – Treatment for Alcohol Dependence

Lundbeck submitted the European Marketing Authorisation Application (MAA) for Nalmefene in December 2011.

Go Top